C2 PHARMA, a company that manufactures and supplies ophthalmic active pharmaceutical ingredients (APIs), has received a Certificate of Suitability (CEP) for Cyclopentolate Hydrochloride by the Quality of Medicines & Health Care (EDQM). This is the second ever CEP granted by the European Directorate for Cyclopentolate Hydrochloride, allowing C2 PHARMA to make the API commercially accessible to customers throughout Europe, Southeast Asia, Oceania and beyond. The synthesis of the API was dev...